Similarly, an in vitro study conducted on mononuclear cells from breast cancer patients showed a significant reduction in tumor growth and HERV-K mediated cytotoxicity on cells treated with HERV-K env protein chimeric antigen receptor (K-CAR) T-cells. This evidence concerns the gene ERVW-1 and breast carcinoma.